'Charm added' presentation slideshows

ESC 2003: Confirming knowledge

ESC 2003: Confirming knowledge. Valentin Fuster MD Director, Cardiovascular Institute Mount Sinai Medical Center New York, NY Christopher Cannon MD Cardiologist Brigham and Women's Hospital Boston, MA James Ferguson MD Associate Director, Cardiology

646 views • 64 slides

Cardiovascular and Renal Drugs Advisory Committee Meeting February 24, 2005 ATACAND (candesartan cilexetil) NDA 20-838/S-022, S-024, S-025 Questions to the Committee.

265 views • 16 slides

Heart failure: The national burden

214 views • 10 slides

Relationship of background ACEI dose to benefits of candesartan in the CHARM-Added trial

Relationship of background ACEI dose to benefits of candesartan in the CHARM-Added trial. CHARM-Added: Study design. C andesartan in H eart failure: A ssessment of R eduction in M ortality and morbidity (CHARM)-Added. Randomized, double-blind

227 views • 7 slides